4CPS-059 Linezolid dosing in patients with liver cirrhosis: standard dosing risks’ toxicity

BACKGROUND: Linezolid is used at a standard dose of 600 mg/12 hours regardless of renal or hepatic function but very little data concerning its pharmacokinetics (PK), efficacy and safety in patients with liver cirrhosis is available. PURPOSE: The objectives were to describe the PK, efficacy and safe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Luque, S, Echeverria-Esnal, D, Martinez-Casanova, J, Gonzalez-Colominas, E, Fernandez-Sala, X, Barcelo, J, Muñoz, R, Alvarez-Lerma, F, Grau, S
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 4: Clinical pharmacy services
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535325/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.150
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars